Enlarged Prostate News and Research

RSS
Saw Palmetto ineffective in patients with enlarged prostate: Study

Saw Palmetto ineffective in patients with enlarged prostate: Study

Impax confirms JALYN patent challenge

Impax confirms JALYN patent challenge

Mylan introduces generic version of Uroxatral for benign prostatic hyperplasia

Mylan introduces generic version of Uroxatral for benign prostatic hyperplasia

Protox reports net loss of $3.2 million for second quarter 2011

Protox reports net loss of $3.2 million for second quarter 2011

GlaxoSmithKline files suit against Watson over generic JALYN

GlaxoSmithKline files suit against Watson over generic JALYN

UIC study reveals potential of lycopene in prostate cancer prevention among African American men

UIC study reveals potential of lycopene in prostate cancer prevention among African American men

Scientists identify molecular mechanism behind alcohol-induced blackouts

Scientists identify molecular mechanism behind alcohol-induced blackouts

Acura, Pfizer receive FDA approval for OXECTA Tablets to manage severe pain

Acura, Pfizer receive FDA approval for OXECTA Tablets to manage severe pain

Counselling can help men overcome fears over sexual performance after prostate surgery

Counselling can help men overcome fears over sexual performance after prostate surgery

Drugs for enlarged prostate raise cancer risk

Drugs for enlarged prostate raise cancer risk

Protox reports net and comprehensive loss of $2.2 million for first quarter 2011

Protox reports net and comprehensive loss of $2.2 million for first quarter 2011

Decade-long study demonstrates immediate, long-term benefits of holmium laser treatment for enlarged prostate

Decade-long study demonstrates immediate, long-term benefits of holmium laser treatment for enlarged prostate

Silodosin helps reduce chronic prostatitis in men

Silodosin helps reduce chronic prostatitis in men

FDA approves Abbott's AndroGel for hypogonadism treatment in men

FDA approves Abbott's AndroGel for hypogonadism treatment in men

Endo Pharmaceuticals to acquire American Medical Systems

Endo Pharmaceuticals to acquire American Medical Systems

Lilly's Axiron testosterone replacement therapy now available in US pharmacies

Lilly's Axiron testosterone replacement therapy now available in US pharmacies

Protox reports net loss of $4.5 million for year ended December 31, 2010

Protox reports net loss of $4.5 million for year ended December 31, 2010

Prostatic artery embolization comparable to transurethral resection

Prostatic artery embolization comparable to transurethral resection

FDA issues Complete Response letter for Avodart sNDA for reduction of prostate cancer risk

FDA issues Complete Response letter for Avodart sNDA for reduction of prostate cancer risk

New study suggests PSA test effective for men with prostate cancer

New study suggests PSA test effective for men with prostate cancer